Subscribe here
Get started today before this once in a lifetime opportunity
Related Articles
Trump picks Dr. Marty Makary, a Johns Hopkins surgeon, for FDA chief
Makary, who will need to be confirmed by the Senate, has defended controversial Trump cabinet pick Robert F. Kennedy Jr.
25% of legislative time is going anti-trans legislation, isn’t that bizarre?
Most Albertans are see healthcare, the cost of living, education, and housing as major issues in the province, and few are talking about trans issues.…
Harper’s economic record the worst in Canada’s postwar history
The Conservatives portray themselves as capable economic managers. But their record proves the opposite.
The Power of Publishing Your Clinical and Research Work
Nursing leader explains how publishing high-quality knowledge advances the science of nursing practice and strengthens an entire healthcare organization.
Metabolic and bariatric surgery safe and effective for patients with severe obesity
A team of researchers led by Pennington Biomedical Research Center’s Dr. Florina Corpodean has confirmed through a data analysis that metabolic and bariatric surgery is…
The Human Cost of Inaction on PBM Reform – DC Journal – InsideSources
The case against pharmacy benefit managers (PBMs) and for much-needed reforms of our broken prescription drug pricing system has been convincingly made.
A Woman’s Journey is empowering women to make informed health care decisions
Dr. Kendall Moseley joins us with information on bone health and how aging can affect women’s bone strength and loss.
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial | Journal of Clinical Oncology
PURPOSETo investigate whether intermittent treatment after an induction phase of first-line schedule of fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus panitumumab (PAN) prevents or delays the…
What’s next in cancer care — Harvard Gazette
In the “Harvard Thinking” podcast, experts discuss advances in technology from genomic sequencing to AI to personalized vaccines.
Dr Pant on the Importance of Targeted Therapy and Mutation Testing in Pancreatic Cancer
Shubham Pant, MD, MBBS, discusses next-generation sequencing in pancreatic cancer, highlighting the importance of targeting RAS mutations when applicable.
